DSD Basics - What's in a Name?
- Definition: Disorders of Sex Development (DSD) are congenital conditions with atypical development of chromosomal, gonadal, or anatomical sex.
- Normal Sexual Differentiation: Key players include:
- SRY gene: Primary testis-determining factor on Y chromosome.
- SOX9: Testis development.
- AMH (Anti-Müllerian Hormone): From Sertoli cells; causes Müllerian duct regression.
- Testosterone: From Leydig cells; develops Wolffian ducts.
- DHT (Dihydrotestosterone): From testosterone via 5α-reductase; virilizes external genitalia.

- Classification:
- Sex Chromosome DSD (e.g., Turner syndrome, Klinefelter syndrome).
- 46,XY DSD (e.g., Androgen Insensitivity Syndrome, 5α-reductase deficiency).
- 46,XX DSD (e.g., Congenital Adrenal Hyperplasia).
ā SRY gene on Y chromosome is the primary testis-determining factor.
46,XX DSD - Ovaries & Androgens
- Ovaries present; virilization due to excess androgens.
- Congenital Adrenal Hyperplasia (CAH): Most common cause.
- 21-Hydroxylase Deficiency (most frequent):
- Ambiguous genitalia in females.
- Salt-wasting (āaldosterone, ārenin) in ~75%.
- Diagnosis: ā17-hydroxyprogesterone (17-OHP).
- 11β-Hydroxylase Deficiency:
- Ambiguous genitalia.
- Hypertension (ādeoxycorticosterone).
- Diagnosis: ā11-deoxycortisol.
- Management: Glucocorticoids, mineralocorticoids (if salt-wasting), surgical correction.
- 21-Hydroxylase Deficiency (most frequent):
- Maternal Androgen Exposure:
- Androgen-secreting tumors (e.g., luteoma).
- Exogenous androgens.
ā The most common cause of 46,XX DSD is 21-hydroxylase deficiency, leading to increased 17-hydroxyprogesterone (17-OHP).
46,XY DSD - Testes & Targets
- 46,XY karyotype with undervirilization due to issues with testes or androgen targets.
- Disorders of Testicular Development:
- Gonadal dysgenesis (e.g., Swyer syndrome): Streak gonads, female phenotype.
- Disorders of Androgen Synthesis/Action:
- 5-alpha-reductase deficiency (5-ARD): "Guevedoces." Ambiguous genitalia at birth, virilization at puberty. āDHT. T/DHT ratio > 20.
- Androgen Insensitivity Syndrome (AIS): Defective androgen receptor.
- Complete (CAIS): Female external genitalia, absent uterus. Testes present.
- Partial (PAIS): Ambiguous genitalia.
- Diagnosis: Karyotype, hormones (T, DHT, LH, AMH), hCG stim test, genetics.

ā Complete Androgen Insensitivity Syndrome (CAIS) presents with a 46,XY karyotype, female external genitalia, absent uterus, and testes producing normal testosterone.
Chromosomal DSDs - Gene Juggle
- Turner Syndrome (45,X): Streak gonads, ovarian dysgenesis, primary amenorrhea.
- Klinefelter Syndrome (47,XXY): Testicular dysgenesis (small testes), azoospermia, gynecomastia.
- Ovotesticular DSD: Ovotestis (ovarian & testicular tissue); variable karyotype (46,XX; 46,XY).
- Gonadal Dysgenesis (e.g., Swyer - 46,XY): Female phenotype, streak gonads.

ā Swyer syndrome (46,XY pure gonadal dysgenesis): streak gonads; gonadectomy vital due to high gonadoblastoma risk.
DSD Approach - Clue Cracking Care
Newborn with ambiguous genitalia: prompt, systematic evaluation.
- History: Maternal (drugs, virilization, family Hx DSD, consanguinity), neonatal.
- Examination: Genital (phallus, gonads, meatus, fusion - Prader staging), dysmorphic features.
- Initial Investigations (Key):
- Karyotype (STAT).
- Serum electrolytes (Na+, K+), glucose.
- Hormones: 17-OHP, Testosterone, AMH.
- Pelvic USG (müllerian structures, gonads).
- Management: MDT essential. Gender assignment: complex decision (diagnosis, surgery, fertility, family values).

ā Karyotyping is the cornerstone initial investigation in evaluating a newborn with ambiguous genitalia.
HighāYield Points - ā” Biggest Takeaways
- Karyotyping is the crucial first investigation for ambiguous genitalia.
- CAH (21-hydroxylase deficiency) is the most common cause of 46,XX DSD virilization.
- AIS (46,XY): female external genitalia, absent uterus, undescended testes; prophylactic gonadectomy.
- 5α-reductase deficiency (46,XY): ambiguous genitalia at birth, virilizes at puberty.
- Swyer Syndrome (46,XY): female, streak gonads, uterus present; high tumor risk, gonadectomy.
- MGD (45,X/46,XY mosaicism): variable phenotype, asymmetric gonads, high tumor risk.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING ā FREEor get the app